Short description
Prof. Dr. Jörg Mittelstät, Professor of Pharmaceutical Biotechnology at Reutlingen University, is researching programmable biomaterials in the "CAR-AdMATRIX" project to enable better and more cost-effective cancer therapy.
![[Translate to English:] Hochschule Reutlingen](/fileadmin/mediamanager/institutions/logos/hochschule_reutlingen.svg "[Translate to English:] Hochschule Reutlingen")
Project overview
Reutlingen University
Here you can find an overview of all the institution's funded projects
4
ongoing projects
4 project descriptions available
A novel adapter-programmable hydrogel matrix for integrated CAR T cell manufacturing (CAR-AdMATRIX) Life Science Technologies, Talents - Individual funding programmes – CZS research boost
Functionalized tympanic membrane implant contact for improved medical care in the field of passive and active hearing implants (TYMP-CONTACT) Life Science Technologies, Transfer - Project funding programmes – CZS Transfer
Short description
The project is researching the development of hearing implants. The surface properties of a tympanic membrane lens are to be optimized for this purpose. To this end, a material platform is to be developed that will make it possible to adapt the surface properties in a targeted manner.
Hearing diagnosis through resonance tracking of the middle ear (HöRTMit) Life Science Technologies, Talents - Individual funding programmes – CZS research boost
Short description
Prof. Simon Peter, Professor of Technical Mechanics at Reutlingen University, is developing a new measurement method for hearing diagnosis. The middle ear is specifically measured and the most relevant vibration variables are recorded with increased efficiency, accuracy and improved interpretability.
In vitro human stem cell-based blood-brain-barrier platform to study drug delivery and neurological diseases (3D-hiPSC-BBB) Life Science Technologies, Talents - Individual funding programmes – CZS research boost
Short description
Prof. Dr. Ebru Ercan Herbst heads the “3D-iPSC-BBB” project at Reutlingen University. The aim is to develop a model for investigating the human blood-brain barrier based on artificially produced pluripotent stem cells.